Skip to main content
PMC home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1980 Oct;42(4):503–509. doi: 10.1038/bjc.1980.272

Immunoglobulins associated with human tumours in vivo: IgG concentrations in eluates of colonic carcinomas.

J M MacSween, S L Eastwood
PMCID: PMC2010443  PMID: 7437286

Abstract

The concentrations of IgG in acidic and 3MKCl eluates of resected colonic carcinomas and adjacent normal tissue were determined by radioimmunoassay. The mean concentration of IgG was significantly higher in both acidic and KCl eluates of primary Dukes Stage C tumours than Dukes Stage A tumours. These results provide direct evidence for increased fixation of IgG in vivo by human colonic cancers which had metastasized. Our results also raise the possibility that IgG is more tightly bound to the Stage C tumours. It is likely that this tumour-associated Ig represents antibody to tumour antigens or antigen-antibody complexes, bound to Fc receptors in the tumour.

Full text

PDF
509

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chard T., French M. E., Batchelor J. R. Enhancement of the C57BL leukemia E.L.4 by Fab fragments of isoantibody. Transplantation. 1967 Sep 5;5(5):1266–1272. doi: 10.1097/00007890-196709000-00004. [DOI] [PubMed] [Google Scholar]
  2. Currie G. A., Alexander P. Spontaneous shedding of TSTA by viable sarcoma cells: its possible role in facilitating metastatic spread. Br J Cancer. 1974 Jan;29(1):72–75. doi: 10.1038/bjc.1974.9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. DUKES C. E., BUSSEY H. J. The spread of rectal cancer and its effect on prognosis. Br J Cancer. 1958 Sep;12(3):309–320. doi: 10.1038/bjc.1958.37. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dickler H. B. Studies of the human lymphocyte receptor for heat-aggregated or antigen-complexed immunoglobulin. J Exp Med. 1974 Aug 1;140(2):508–522. doi: 10.1084/jem.140.2.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ehrlich R., Witz I. P. The elution of antibodies from viable murine tumor cells. J Immunol Methods. 1979;26(4):345–353. doi: 10.1016/0022-1759(79)90180-7. [DOI] [PubMed] [Google Scholar]
  6. Fidler I. J., Kripke M. L. Metastasis results from preexisting variant cells within a malignant tumor. Science. 1977 Aug 26;197(4306):893–895. doi: 10.1126/science.887927. [DOI] [PubMed] [Google Scholar]
  7. GREENWOOD F. C., HUNTER W. M., GLOVER J. S. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. Biochem J. 1963 Oct;89:114–123. doi: 10.1042/bj0890114. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Izsak F. C., Brenner H. J., Landes E., Ran M., Witz I. P. Correlation between clinico-pathological features of malignant tumors and cell surface immunoglobulins. Isr J Med Sci. 1974 Jun;10(6):642–646. [PubMed] [Google Scholar]
  9. Keisari Y., Witz I. P. Degradation of cell-bound antibodies by tumor cells from C57BL/6 mice. J Natl Cancer Inst. 1978 Oct;61(4):1135–1141. [PubMed] [Google Scholar]
  10. Keisari Y., Witz I. P. Degradation of immunoglobulins by lysosomal enzymes of tumors. I. Demonstration of the phenomenon using mouse tumors. Immunochemistry. 1973 Sep;10(9):565–570. doi: 10.1016/0019-2791(73)90156-0. [DOI] [PubMed] [Google Scholar]
  11. Meltzer M. S., Leonard E. J., Rapp H. J., Borsos T. Tumor-specific antigen solubilized by hypertonic potassium chloride. J Natl Cancer Inst. 1971 Sep;47(3):703–709. [PubMed] [Google Scholar]
  12. Moav N., Witz I. P. Characterization of immunoglobulins eluted from murine tumor cells: binding patterns of cytotoxic anti-tumor IgG. J Immunol Methods. 1978;22(1-2):51–62. doi: 10.1016/0022-1759(78)90057-1. [DOI] [PubMed] [Google Scholar]
  13. Moretta L., Mingari M. C., Moretta A., Cooper M. D. Human T lymphocyte subpopulations: studies of the mechanism by which T cells bearing Fc receptors for IgG suppress T-dependent B cell differentiation induced by pokeweed mitogen. J Immunol. 1979 Mar;122(3):984–990. [PubMed] [Google Scholar]
  14. Old L. J., Boyse E. A. Specific antigens of tumors and leukemias of experimental animals. Med Clin North Am. 1966 May;50(3):901–912. doi: 10.1016/s0025-7125(16)33187-x. [DOI] [PubMed] [Google Scholar]
  15. Perlmann P., Troye M., Pape G. R. Cell-mediated immune reactions to human tumors. Cancer. 1977 Jul;40(1 Suppl):448–457. doi: 10.1002/1097-0142(197707)40:1+<448::aid-cncr2820400707>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  16. Pincus J. H. Solubilization of biologically active cell surface antigens. Contemp Top Mol Immunol. 1976;5:87–124. doi: 10.1007/978-1-4684-8142-6_4. [DOI] [PubMed] [Google Scholar]
  17. Prehn R. T. The immune reaction as a stimulator of tumor growth. Science. 1972 Apr 14;176(4031):170–171. doi: 10.1126/science.176.4031.170. [DOI] [PubMed] [Google Scholar]
  18. Ran M., Klein G., Witz I. P. Tumor-bound immunoglobulins. Evidence for the in vivo coating of tumor cells by potentially cytotoxic anti-tumour antibodies. Int J Cancer. 1976 Jan 15;17(1):90–97. doi: 10.1002/ijc.2910170113. [DOI] [PubMed] [Google Scholar]
  19. Schirrmacher V., Jacobs W. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VIII. Expression and shedding of Fc gamma receptors on metastatic tumor cell variants. J Supramol Struct. 1979;11(1):105–111. doi: 10.1002/jss.400110111. [DOI] [PubMed] [Google Scholar]
  20. Scornik J. C., Klein P. A. Antibody-dependent lysis of tumor cells in vivo. I. Early lysis of tumor cells. J Natl Cancer Inst. 1978 Oct;61(4):1143–1148. [PubMed] [Google Scholar]
  21. Shearer W. T., Philpott G. W., Parker C. W. Stimulation of cells by antibody. Science. 1973 Dec 28;182(4119):1357–1359. doi: 10.1126/science.182.4119.1357. [DOI] [PubMed] [Google Scholar]
  22. Sjögren H. O., Hellström I., Bansal S. C., Warner G. A., Hellström K. E. Elution of "blocking factors" from human tumors, capable of abrogating tumor-cell destruction by specifically immune lymphocytes. Int J Cancer. 1972 Mar 15;9(2):274–283. doi: 10.1002/ijc.2910090205. [DOI] [PubMed] [Google Scholar]
  23. Sugarbaker E. V. Some characteristics of metastasis in man. Am J Pathol. 1979 Dec;97(3):623–632. [PMC free article] [PubMed] [Google Scholar]
  24. Tönder O., Krishnan E. C., Jewell W. R., Morse P. A., Jr, Humphrey L. J. Tumor Fc receptors and tumor-associated immunoglobulins. Acta Pathol Microbiol Scand C. 1976 Apr;84(2):105–111. doi: 10.1111/j.1699-0463.1976.tb00006.x. [DOI] [PubMed] [Google Scholar]
  25. Vánky F., Trempe G., Klein E., Stjernswärd Human tumor--lymphocyte interaction in vitro: blastogenesis correlated to detectable immunoglobulin in the biopsy. Int J Cancer. 1975 Jul 15;16(1):113–124. doi: 10.1002/ijc.2910160113. [DOI] [PubMed] [Google Scholar]
  26. Weksler M. E., Kuntz M. M., Birnbaum G., Innes J. B. Lymphocyte transformation induced by autologous cells. Fed Proc. 1978 Aug;37(10):2370–2373. [PubMed] [Google Scholar]
  27. Wesenberg F. Fc gamma receptors and IgG associated with human malignant tumours. Acta Pathol Microbiol Scand C. 1978 Oct;86C(5):259–263. doi: 10.1111/j.1699-0463.1978.tb02589.x. [DOI] [PubMed] [Google Scholar]
  28. Witz I. P., Kinamon S., Ran M., Klein G. Tumour-bound immunoglobulins. The in vitro fixation of radioiodine-labelled anti-immunoglobulin reagents by tumour cells. Clin Exp Immunol. 1974 Mar;16(3):321–333. [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES